Fierce Healthcare

FEBRUARY 2, 2022

HHS: Disparities in video telehealth use highlight key barriers to access. rking. Wed, 02/02/2022 - 13:45.

144

144

pharmaphorum

FEBRUARY 2, 2022

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products. The litigation extends back to 2018, when ViiV – a joint venture majority owned by GlaxoSmithKline alongside Pfizer and Shionogi – accused Gilead of infringing its patents on HIV integrase inhibitor dolutegravir.

Compounding 72

Compounding FDA 72

Fierce Healthcare

FEBRUARY 2, 2022

HealthRhythms lands UCHealth partnership, $11M investment to scale up AI-based mental health app. hlandi. Wed, 02/02/2022 - 15:39.

116

116

pharmaphorum

FEBRUARY 2, 2022

French health wearables company Withings has agreed a deal to acquire 8fit, a German digital health company whose personalised workout and meal-planning app is used by millions of people around the world. The app offers thousands of supervised and customisable workouts such as high intensity interval training (HIIT), boxing, Pilates, yoga or meditation, along with hundreds of healthy recipes, aiming to move beyond sports and fitness into long-term health maintenance.

Chemotherapy 64

Chemotherapy 64

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

FEBRUARY 2, 2022

Warren calls for end to Direct Contracting, reforms to Medicare Advantage risk adjustment. rking. Wed, 02/02/2022 - 16:57.

119

119

NICE

FEBRUARY 2, 2022

From sensor-enabled glasses that facilitate self-management for major depression to devices that measure muscle performance to improve a person’s gait, NICE has worked in partnership with Innovate UK and the University of Manchester to support 16 digital health technology (DHT) developers over the last three years as part of the Digital Health Technology Catalyst.

Packaging 52

Packaging 52

Pharma Mirror

FEBRUARY 2, 2022

Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the Biologics market, with a particular focus on drug substance manufacturing of novel ATMPs.

52

52

Fierce Healthcare

FEBRUARY 2, 2022

Magellan Health partners with Zipline to deliver prescriptions by drone. rtorrence. Wed, 02/02/2022 - 15:25.

116

116

pharmaphorum

FEBRUARY 2, 2022

Pharming has taken a step closer to getting a second product to market, after its rare disease therapy leniolisib met its objectives in a pivotal trial, setting up regulatory filings in the coming months. The Netherlands biotech is developing leniolisib (formerly CDZ173) under license from Novartis for activated PI3K delta syndrome (APDS), an ultra-rare disease with no approved therapies that causes severe immune deficiency and a risk of blood cancers.

Immunization 52

Immunization Labelling FDA 52

Fierce Healthcare

FEBRUARY 2, 2022

Vizient: Drug prices for hospitals to increase 3% in 2022, with remdesivir topping adalimumab in total spend. dmuoio. Wed, 02/02/2022 - 16:48.

Hospitals 98

Hospitals 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

FEBRUARY 2, 2022

Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream. Now, as the sector settles back into something approaching business as usual, how can we ensure new methodologies are delivering for participants, sites, and the sector alike? As the COVID-19 pandemic ricocheted around the world at the start of 2020, researchers were faced with a stark choice – go remote or go home.

Documentation 52

Documentation Packaging Communication 52

Fierce Healthcare

FEBRUARY 2, 2022

DOJ recovers over $5B in healthcare fraud settlements, judgments in 2021. dmuoio. Wed, 02/02/2022 - 12:13.

111

111

Med Ed 101

FEBRUARY 2, 2022

KE is a 79 year old female who is complaining of an increase in urinary incontinence. Specifically, frequent urination has been a problem with small amounts of leakage. She is wondering what medications she can take to help alleviate this problem. She has been diagnosed with overactive bladder previously but has not wanted to take […]. The post Urinary Incontinence – Case Study appeared first on Med Ed 101.

40

40

Fierce Healthcare

FEBRUARY 2, 2022

Humana outlines its strategy to bounce back after MA growth for 2022 underwhelms. pminemyer. Wed, 02/02/2022 - 07:30.

105

105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

FEBRUARY 2, 2022

Boost for patients with life-threatening conditions who require access to medicines not yet authorised for marketing

42

42

Fierce Healthcare

FEBRUARY 2, 2022

CMS puts focus on health equity in Medicare Advantage, Part D Advance Notice. pminemyer. Wed, 02/02/2022 - 16:58.

98

98

Pharma Times

FEBRUARY 2, 2022

Coalition urges reformation of EU-wide drug research and development to drive treatment optimisation

43

43

Fierce Healthcare

FEBRUARY 2, 2022

City of Hope closes acquisition of Cancer Treatment Centers of America. dmuoio. Wed, 02/02/2022 - 14:41.

98

98

pharmaphorum

FEBRUARY 2, 2022

Robert Califf has made a series of commitments to try to win over senators reluctant to back his nomination as the next FDA commissioner, ahead of the deciding vote on his appointment. In a letter to one of those he needs to win over – senior Democrat Senator Elizabeth Warren – Califf has said he will not take up any employment or payment from pharma or medical device companies he interacts with whilst at the regulator for four years after he leaves.

FDA 59

FDA 59

Fierce Healthcare

FEBRUARY 2, 2022

Sex therapy app Lover joins FDA SteP program, raises $2M in bridge round. agliadkovskaya. Wed, 02/02/2022 - 17:33.

FDA 105

FDA 105